Syndax Pharmaceuticals Return on Tangible Equity 2015-2024 | SNDX

Current and historical return on tangible equity values for Syndax Pharmaceuticals (SNDX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Syndax Pharmaceuticals Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.30B $0.37B -64.14%
2024-06-30 $-0.26B $0.43B -57.21%
2024-03-31 $-0.24B $0.49B -53.19%
2023-12-31 $-0.21B $0.55B -47.80%
2023-09-30 $-0.18B $0.36B -42.36%
2023-06-30 $-0.16B $0.40B -39.00%
2023-03-31 $-0.15B $0.44B -38.18%
2022-12-31 $-0.15B $0.47B -38.65%
2022-09-30 $-0.01B $0.34B -3.78%
2022-06-30 $0.00B $0.36B 0.00%
2022-03-31 $0.02B $0.38B 5.01%
2021-12-31 $0.02B $0.41B 9.14%
2021-09-30 $-0.09B $0.20B -41.16%
2021-06-30 $-0.09B $0.22B -44.50%
2021-03-31 $-0.09B $0.23B -45.26%
2020-12-31 $-0.08B $0.25B -52.56%
2020-09-30 $-0.07B $0.13B -77.60%
2020-06-30 $-0.06B $0.15B -90.65%
2020-03-31 $-0.06B $0.05B -131.89%
2019-12-31 $-0.06B $0.03B -112.00%
2019-09-30 $-0.06B $0.04B -110.41%
2019-06-30 $-0.07B $0.06B -107.88%
2019-03-31 $-0.07B $0.07B -106.25%
2018-12-31 $-0.07B $0.05B -106.57%
2018-09-30 $-0.07B $0.06B -89.85%
2018-06-30 $-0.07B $0.07B -79.33%
2018-03-31 $-0.07B $0.09B -67.51%
2017-12-31 $-0.06B $0.10B -63.71%
2017-09-30 $-0.05B $0.10B -58.40%
2017-06-30 $-0.05B $0.11B -58.89%
2017-03-31 $-0.05B $0.07B -52.66%
2016-12-31 $-0.05B $0.08B -47.24%
2016-09-30 $-0.04B $0.09B -43.04%
2016-06-30 $-0.08B $0.11B -115.68%
2016-03-31 $-0.08B $0.11B -179.01%
2015-12-31 $-0.07B $0.07B -435.82%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.420B $0.140B
Syndax Pharmaceuticals, Inc. is a biopharmaceutical company which focused on the development and commercialization of entinostat, an epigenetic therapy for treatment-resistant cancers. The Company's product pipeline includes ENCORE 601, ENCORE 602, J1353, NCI-7870, NCI-9844, E2112, NCI-8871 and NCI-9253 which are in clinical trial stage. Syndax Pharmaceuticals, Inc. is based in WALTHAM, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $162.034B 15.68
Vertex Pharmaceuticals (VRTX) United States $127.377B 0.00
Bristol Myers Squibb (BMY) United States $118.466B 49.92
Gilead Sciences (GILD) United States $115.442B 20.91
CSL (CSLLY) Australia $89.975B 0.00
Regeneron Pharmaceuticals (REGN) United States $88.387B 20.12
GSK (GSK) United Kingdom $72.767B 8.42
Argenex SE (ARGX) Netherlands $35.839B 0.00
Alnylam Pharmaceuticals (ALNY) United States $34.128B 0.00
BioNTech SE (BNTX) Germany $26.726B 0.00
Biogen (BIIB) United States $24.159B 10.38
Illumina (ILMN) United States $23.183B 84.49
BeiGene (BGNE) Cayman Islands $19.036B 0.00
Moderna (MRNA) United States $16.216B 0.00
Incyte (INCY) United States $15.504B 0.00
Genmab (GMAB) Denmark $14.334B 21.03
BioMarin Pharmaceutical (BMRN) United States $12.704B 29.50
Insmed (INSM) United States $12.631B 0.00
Bio-Techne Corp (TECH) United States $12.065B 46.58
Vaxcyte (PCVX) United States $12.044B 0.00
Sarepta Therapeutics (SRPT) United States $10.744B 96.97
Exelixis (EXEL) United States $10.050B 22.85
Revolution Medicines (RVMD) United States $9.779B 0.00
QIAGEN (QGEN) Netherlands $9.728B 20.01
Exact Sciences (EXAS) United States $9.389B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Intra-Cellular Therapies (ITCI) United States $9.353B 0.00
Roivant Sciences (ROIV) United Kingdom $8.837B 0.00
Repligen (RGEN) United States $8.427B 109.83
Ascendis Pharma (ASND) Denmark $7.643B 0.00
Halozyme Therapeutics (HALO) United States $7.457B 16.84
Legend Biotech (LEGN) United States $7.174B 0.00
Cytokinetics (CYTK) United States $6.604B 0.00
Avidity Biosciences (RNA) United States $6.264B 0.00
Blueprint Medicines (BPMC) United States $6.154B 0.00
Viking Therapeutics (VKTX) United States $6.136B 0.00
Nuvalent (NUVL) United States $5.854B 0.00
Arcellx (ACLX) United States $5.415B 0.00
Krystal Biotech (KRYS) United States $5.298B 87.72
ADMA Biologics Inc (ADMA) United States $5.004B 53.67
Biohaven (BHVN) United States $4.959B 0.00
Axsome Therapeutics (AXSM) United States $4.741B 0.00
Alkermes (ALKS) Ireland $4.731B 15.89
Ultragenyx Pharmaceutical (RARE) United States $4.498B 0.00
Denali Therapeutics (DNLI) United States $4.264B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.250B 0.00
Immunovant (IMVT) United States $4.242B 0.00
Guardant Health (GH) United States $3.906B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.692B 0.00
Apellis Pharmaceuticals (APLS) United States $3.514B 0.00
Merus (MRUS) Netherlands $3.487B 0.00
ImmunityBio (IBRX) United States $3.364B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.262B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.200B 0.00
Kymera Therapeutics (KYMR) United States $3.150B 0.00
Edgewise Therapeutics (EWTX) United States $3.149B 0.00
Amicus Therapeutics (FOLD) United States $3.099B 0.00
Zai Lab (ZLAB) China $2.983B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.970B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.952B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.927B 22.55
Iovance Biotherapeutics (IOVA) United States $2.743B 0.00
Vericel (VCEL) United States $2.738B 924.50
Janux Therapeutics (JANX) United States $2.729B 0.00
Vera Therapeutics (VERA) United States $2.710B 0.00
IDEAYA Biosciences (IDYA) United States $2.635B 0.00
SpringWorks Therapeutics (SWTX) United States $2.582B 0.00
Scholar Rock Holding (SRRK) United States $2.563B 0.00
Keros Therapeutics (KROS) United States $2.555B 0.00
Protagonist Therapeutics (PTGX) United States $2.543B 16.04
Belite Bio (BLTE) United States $2.517B 0.00
Twist Bioscience (TWST) United States $2.489B 0.00
Apogee Therapeutics (APGE) United States $2.377B 0.00
CG Oncology (CGON) United States $2.358B 0.00
Geron (GERN) United States $2.339B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.325B 0.00
Ligand Pharmaceuticals (LGND) United States $2.307B 57.58
Beam Therapeutics (BEAM) United States $2.277B 0.00
Bavarian Nordic (BVNRY) Denmark $2.221B 11.89
Akero Therapeutics (AKRO) United States $2.162B 0.00
NeoGenomics (NEO) United States $2.109B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.108B 0.00
Structure Therapeutics (GPCR) United States $2.080B 0.00
WAVE Life Sciences (WVE) Singapore $1.957B 0.00
NovoCure (NVCR) Jersey $1.936B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.930B 16.04
Nurix Therapeutics (NRIX) United States $1.923B 0.00
MannKind (MNKD) United States $1.919B 49.71
Fortrea Holdings (FTRE) United States $1.909B 60.80
Disc Medicine (IRON) United States $1.875B 0.00
Galapagos (GLPG) Belgium $1.816B 0.00
Viridian Therapeutics (VRDN) United States $1.781B 0.00
Celldex Therapeutics (CLDX) United States $1.781B 0.00
Dynavax Technologies (DVAX) United States $1.777B 104.00
Tarsus Pharmaceuticals (TARS) United States $1.769B 0.00
Arvinas (ARVN) United States $1.741B 0.00
Neumora Therapeutics (NMRA) United States $1.741B 0.00
Certara (CERT) United States $1.724B 48.68
Immunocore Holdings (IMCR) United Kingdom $1.709B 0.00
Spyre Therapeutics (SYRE) United States $1.696B 0.00
Intellia Therapeutics (NTLA) United States $1.641B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.633B 0.00
Praxis Precision Medicines (PRAX) United States $1.523B 0.00
Arcus Biosciences (RCUS) United States $1.504B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.498B 0.00
Travere Therapeutics (TVTX) United States $1.449B 0.00
Myriad Genetics (MYGN) United States $1.437B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.428B 0.00
Upstream Bio (UPB) United States $1.389B 0.00
Kura Oncology (KURA) United States $1.380B 0.00
Gyre Therapeutics (GYRE) United States $1.353B 0.00
Mesoblast (MESO) Australia $1.336B 0.00
ANI Pharmaceuticals (ANIP) United States $1.259B 17.14
Novavax (NVAX) United States $1.244B 0.00
Vir Biotechnology (VIR) United States $1.237B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.225B 0.00
Zymeworks (ZYME) United States $1.185B 0.00
Bicara Therapeutics (BCAX) United States $1.139B 0.00
Cogent Biosciences (COGT) United States $1.138B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.104B 0.00
MiMedx (MDXG) United States $1.098B 28.73
ArriVent BioPharma (AVBP) United States $1.070B 0.00
Applied Therapeutics (APLT) United States $1.038B 0.00
Immatics (IMTX) Germany $1.023B 0.00
LENZ Therapeutics (LENZ) United States $0.999B 0.00
Septerna (SEPN) $0.975B 0.00
89BIO (ETNB) United States $0.946B 0.00
Prothena (PRTA) Ireland $0.927B 0.00
Cullinan Therapeutics (CGEM) United States $0.919B 0.00
Castle Biosciences (CSTL) United States $0.891B 159.00
CARGO Therapeutics (CRGX) United States $0.876B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.875B 0.00
Cytek Biosciences (CTKB) United States $0.873B 0.00
Adaptive Biotechnologies (ADPT) United States $0.863B 0.00
AbCellera Biologics (ABCL) Canada $0.862B 0.00
Pliant Therapeutics (PLRX) United States $0.838B 0.00
Erasca (ERAS) United States $0.806B 0.00
Replimune (REPL) United States $0.800B 0.00
Rapport Therapeutics (RAPP) United States $0.799B 0.00
Tyra Biosciences (TYRA) United States $0.796B 0.00
Liquidia Technologies (LQDA) United States $0.789B 0.00
Dianthus Therapeutics (DNTH) United States $0.780B 0.00
Avid Bioservices (CDMO) United States $0.778B 0.00
Zenas BioPharma (ZBIO) United States $0.760B 0.00
Pacira BioSciences (PCRX) United States $0.760B 7.15
Anavex Life Sciences (AVXL) United States $0.754B 0.00
Entrada Therapeutics (TRDA) United States $0.747B 12.55
Stoke Therapeutics (STOK) United States $0.736B 0.00
Nuvation Bio (NUVB) United States $0.735B 0.00
Oric Pharmaceuticals (ORIC) United States $0.725B 0.00
BioAge Labs (BIOA) United States $0.723B 0.00
MBX Biosciences (MBX) United States $0.697B 0.00
Immunome (IMNM) United States $0.696B 0.00
Annexon (ANNX) United States $0.692B 0.00
Arbutus Biopharma (ABUS) United States $0.692B 0.00
Tectonic Therapeutic (TECX) United States $0.690B 0.00
CorMedix Inc (CRMD) United States $0.689B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.667B 0.00
IGM Biosciences (IGMS) United States $0.661B 0.00
Olema Pharmaceuticals (OLMA) United States $0.658B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Abivax SA (ABVX) France $0.644B 0.00
Third Harmonic Bio (THRD) United States $0.642B 0.00
Humacyte (HUMA) United States $0.637B 0.00
AnaptysBio (ANAB) United States $0.631B 0.00
Mineralys Therapeutics (MLYS) United States $0.620B 0.00
CureVac (CVAC) Germany $0.616B 5.00
Mind Medicine (MindMed) (MNMD) United States $0.606B 0.00
Astria Therapeutics (ATXS) United States $0.599B 0.00
ACELYRIN, INC (SLRN) United States $0.597B 0.00
Oculis Holding AG (OCS) Switzerland $0.596B 0.00
Sana Biotechnology (SANA) United States $0.594B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.590B 0.00
Terns Pharmaceuticals (TERN) United States $0.576B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.576B 0.00
Allogene Therapeutics (ALLO) United States $0.570B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.555B 0.00
Pharming Group (PHAR) Netherlands $0.549B 0.00
Celcuity (CELC) United States $0.542B 0.00
Emergent Biosolutions (EBS) United States $0.540B 0.00
ChromaDex (CDXC) United States $0.535B 701.00
Monte Rosa Therapeutics (GLUE) United States $0.530B 0.00
REGENXBIO (RGNX) United States $0.529B 0.00
PureTech Health (PRTC) United States $0.521B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.521B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.520B 0.00
Prime Medicine (PRME) United States $0.519B 0.00
Aura Biosciences (AURA) United States $0.516B 0.00
Neurogene (NGNE) United States $0.515B 0.00
Alumis (ALMS) United States $0.510B 0.00
Sangamo Therapeutics (SGMO) United States $0.509B 0.00
Alector (ALEC) United States $0.502B 0.00
GRAIL (GRAL) United States $0.494B 0.00
Foghorn Therapeutics (FHTX) United States $0.492B 0.00
Q32 Bio (QTTB) United States $0.484B 0.00
Contineum Therapeutics (CTNM) United States $0.482B 0.00
GH Research (GHRS) Ireland $0.481B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.478B 0.00
MeiraGTx Holdings (MGTX) United States $0.457B 0.00
Revance Therapeutics (RVNC) United States $0.445B 0.00
Cartesian Therapeutics (RNAC) United States $0.435B 0.00
Design Therapeutics (DSGN) United States $0.425B 0.00
BioStem Technologies (BSEM) $0.388B 34.35
Northwest Biotherapeutics (NWBO) United States $0.384B 0.00
Tango Therapeutics (TNGX) United States $0.382B 0.00
MaxCyte (MXCT) United States $0.374B 0.00
Voyager Therapeutics (VYGR) United States $0.365B 9.42
C4 Therapeutics (CCCC) United States $0.362B 0.00
Absci (ABSI) United States $0.361B 0.00
EnGene Holdings (ENGN) Canada $0.359B 0.00
XOMA Royalty (XOMA) United States $0.350B 0.00
Kamada (KMDA) Israel $0.347B 21.54
Jasper Therapeutics (JSPR) United States $0.344B 0.00
Alpha Teknova (TKNO) United States $0.333B 0.00
UniQure (QURE) Netherlands $0.331B 0.00
Codexis (CDXS) United States $0.329B 0.00
Rezolute (RZLT) United States $0.327B 0.00
Sutro Biopharma (STRO) United States $0.325B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.323B 0.00
Mersana Therapeutics (MRSN) United States $0.323B 0.00
ITeos Therapeutics (ITOS) United States $0.323B 0.00
Poseida Therapeutics (PSTX) United States $0.320B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.318B 0.00
Nautilus Biotechnology (NAUT) United States $0.310B 0.00
AC Immune (ACIU) Switzerland $0.310B 0.00
Semper Paratus Acquisition (TVGN) United States $0.307B 0.00
ATyr Pharma (ATYR) United States $0.295B 0.00
Zura Bio (ZURA) United States $0.294B 0.00
Kodiak Sciences (KOD) United States $0.289B 0.00
Urogen Pharma (URGN) United States $0.285B 0.00
Artiva Biotherapeutics (ARTV) United States $0.284B 0.00
Atea Pharmaceuticals (AVIR) United States $0.283B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.279B 0.00
TScan Therapeutics (TCRX) United States $0.278B 0.00
Ocugen (OCGN) United States $0.276B 0.00
Eton Pharmaceuticals (ETON) United States $0.274B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.273B 0.00
Prima BioMed (IMMP) Australia $0.272B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.268B 0.00
Abeona Therapeutics (ABEO) United States $0.264B 0.00
Lifecore Biomedical (LFCR) United States $0.261B 0.00
GENFIT S.A (GNFT) France $0.260B 0.00
Biomea Fusion (BMEA) United States $0.257B 0.00
Anika Therapeutics (ANIK) United States $0.250B 0.00
Fate Therapeutics (FATE) United States $0.247B 0.00
Editas Medicine (EDIT) United States $0.244B 0.00
Climb Bio (CLYM) United States $0.237B 0.00
Amarin (AMRN) Ireland $0.234B 0.00
Compass Therapeutics (CMPX) United States $0.233B 0.00
Precigen (PGEN) United States $0.231B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.231B 0.00
Inozyme Pharma (INZY) United States $0.228B 0.00
Inhibrx Biosciences (INBX) United States $0.224B 0.00
Fulcrum Therapeutics (FULC) United States $0.222B 0.00
Solid Biosciences (SLDB) United States $0.222B 0.00
Trevi Therapeutics (TRVI) United States $0.220B 0.00
Opthea (OPT) Australia $0.218B 0.00
Kyverna Therapeutics (KYTX) United States $0.218B 0.00
XBiotech (XBIT) United States $0.216B 0.00
2seventy Bio (TSVT) United States $0.213B 0.00
Nuvectis Pharma (NVCT) United States $0.206B 0.00
Nkarta (NKTX) United States $0.205B 0.00
Instil Bio (TIL) United States $0.205B 0.00
Molecular Partners AG (MOLN) Switzerland $0.202B 0.00
Caribou Biosciences (CRBU) United States $0.199B 0.00
CAMP4 Therapeutics (CAMP) United States $0.199B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.197B 0.00
Cabaletta Bio (CABA) United States $0.196B 0.00
ScPharmaceuticals (SCPH) United States $0.196B 0.00
Bright Minds Biosciences (DRUG) United States $0.187B 0.00
Gossamer Bio (GOSS) United States $0.185B 0.00
Sagimet Biosciences (SGMT) United States $0.185B 0.00
Verastem (VSTM) United States $0.182B 0.00
DiaMedica Therapeutics (DMAC) United States $0.182B 0.00
Black Diamond Therapeutics (BDTX) United States $0.177B 0.00
Greenwich LifeSciences (GLSI) United States $0.175B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.169B 0.00
Actuate Therapeutics (ACTU) United States $0.167B 0.00
Tenaya Therapeutics (TNYA) United States $0.166B 0.00
Checkpoint Therapeutics (CKPT) United States $0.163B 0.00
Skye Bioscience (SKYE) United States $0.161B 0.00
Akoya Biosciences (AKYA) United States $0.159B 0.00
Adverum Biotechnologies (ADVM) United States $0.157B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.152B 0.00
Cardiff Oncology (CRDF) United States $0.152B 0.00
PepGen (PEPG) United States $0.148B 0.00
Puma Biotechnology (PBYI) United States $0.146B 6.19
Ventyx Biosciences (VTYX) United States $0.143B 0.00
Scilex Holding (SCLX) United States $0.142B 0.00
Seer (SEER) United States $0.142B 0.00
Compugen (CGEN) Israel $0.142B 79.50
Oncobiologics (OTLK) United States $0.141B 0.00
Inventiva S.A (IVA) France $0.140B 0.00
Repare Therapeutics (RPTX) Canada $0.139B 0.00
Candel Therapeutics (CADL) United States $0.138B 0.00
Vigil Neuroscience (VIGL) United States $0.137B 0.00
Innate Pharma S.A (IPHA) France $0.136B 0.00
Rani Therapeutics Holdings (RANI) United States $0.132B 0.00
Inovio Pharmaceuticals (INO) United States $0.129B 0.00
Elutia (ELUT) United States $0.128B 0.00
INmune Bio (INMB) United States $0.127B 0.00
Adherex Technologies (FENC) United States $0.123B 0.00
Generation Bio (GBIO) United States $0.122B 0.00
Alto Neuroscience (ANRO) United States $0.122B 0.00
Coya Therapeutics (COYA) United States $0.121B 0.00
Adlai Nortye (ANL) Cayman Islands $0.116B 0.00
Allakos (ALLK) United States $0.116B 0.00
Benitec Biopharma (BNTC) United States $0.110B 0.00
Cellectis S.A (CLLS) France $0.110B 0.00
FibroBiologics (FBLG) United States $0.108B 0.00
Invivyd (IVVD) United States $0.106B 0.00
Immunic (IMUX) United States $0.105B 0.00
Adagene (ADAG) China $0.105B 0.00
23andMe Holding (ME) United States $0.104B 0.00
Annovis Bio (ANVS) United States $0.102B 0.00
Monopar Therapeutics (MNPR) United States $0.101B 0.00
PDS Biotechnology (PDSB) United States $0.101B 0.00
InflaRx (IFRX) Germany $0.101B 0.00
Seres Therapeutics (MCRB) United States $0.100B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.098B 0.00
MediciNova (MNOV) United States $0.098B 0.00
Cidara Therapeutics (CDTX) United States $0.098B 0.00
Renovaro (RENB) United States $0.097B 0.00
Genelux (GNLX) United States $0.097B 0.00
BioAtla (BCAB) United States $0.096B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.095B 0.00
HilleVax (HLVX) United States $0.095B 0.00
Adicet Bio (ACET) United States $0.094B 0.00
Genenta Science S.p.A (GNTA) Italy $0.091B 0.00
Werewolf Therapeutics (HOWL) United States $0.091B 0.00
Coherus BioSciences (CHRS) United States $0.090B 0.00
Ovid Therapeutics (OVID) United States $0.087B 0.00
Chimerix (CMRX) United States $0.085B 0.00
I-Mab (IMAB) China $0.085B 0.00
Ikena Oncology (IKNA) United States $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.082B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.082B 0.00
Clearside Biomedical (CLSD) United States $0.082B 0.00
Galena Biopharma (SLS) United States $0.082B 0.00
Boundless Bio (BOLD) United States $0.080B 0.00
Oncolytics Biotech (ONCY) Canada $0.079B 0.00
CytomX Therapeutics (CTMX) United States $0.079B 5.94
VistaGen Therapeutics (VTGN) United States $0.079B 0.00
Celularity (CELU) United States $0.078B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.077B 0.00
Aileron Therapeutics (ALRN) United States $0.077B 0.00
Leap Therapeutics (LPTX) United States $0.077B 0.00
ZIVO Bioscience (ZIVO) United States $0.076B 0.00
Aerovate Therapeutics (AVTE) United States $0.076B 0.00
TELA Bio (TELA) United States $0.076B 0.00
Bluebird Bio (BLUE) United States $0.073B 0.00
Cue Biopharma (CUE) United States $0.073B 0.00
BeyondSpring (BYSI) United States $0.072B 0.00
Agenus (AGEN) United States $0.071B 0.00
Spero Therapeutics (SPRO) United States $0.071B 3.20
ALX Oncology Holdings (ALXO) United States $0.071B 0.00
CervoMed (CRVO) United States $0.069B 0.00
Quince Therapeutics (QNCX) United States $0.069B 0.00
Vor Biopharma (VOR) $0.066B 0.00
IO Biotech (IOBT) Denmark $0.064B 0.00
Aligos Therapeutics (ALGS) United States $0.063B 0.00
Precision BioSciences (DTIL) United States $0.062B 0.00
DBV Technologies S.A (DBVT) France $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
Omega Therapeutics (OMGA) United States $0.059B 0.00
Shattuck Labs (STTK) United States $0.058B 0.00
Affimed (AFMD) Germany $0.057B 0.00
OnKure Therapeutics (OKUR) United States $0.056B 0.00
Theratechnologies (THTX) Canada $0.056B 0.00
Elicio Therapeutics (ELTX) United States $0.056B 0.00
Connect Biopharma Holdings (CNTB) United States $0.056B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.055B 0.00
Kezar Life Sciences (KZR) United States $0.055B 0.00
Rapt Therapeutics (RAPT) United States $0.055B 0.00
Aadi Bioscience (AADI) United States $0.053B 0.00
Kronos Bio (KRON) United States $0.053B 0.00
Immuneering (IMRX) United States $0.051B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.049B 0.00
BGM Group (BGM) China $0.047B 0.00
X4 Pharmaceuticals (XFOR) United States $0.047B 0.00
Rallybio (RLYB) United States $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.045B 0.00
Imunon (IMNN) United States $0.045B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.045B 0.00
Xilio Therapeutics (XLO) United States $0.044B 0.00
Immix Biopharma (IMMX) United States $0.043B 0.00
Intensity Therapeutics (INTS) United States $0.043B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.042B 0.00
HOOKIPA Pharma (HOOK) United States $0.041B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.040B 0.00
NextCure (NXTC) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Fortress Biotech (FBIO) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
Elevation Oncology (ELEV) United States $0.037B 0.00
CalciMedica (CALC) United States $0.037B 0.00
Passage Bio (PASG) United States $0.036B 0.00
Lexaria Bioscience (LEXX) Canada $0.036B 0.00
Opus Genetics (IRD) United States $0.034B 0.00
Pluri (PLUR) Israel $0.034B 0.00
Dyadic (DYAI) United States $0.033B 0.00
Clene (CLNN) United States $0.033B 0.00
Dare Bioscience (DARE) United States $0.033B 0.00
KALA BIO (KALA) United States $0.032B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.031B 0.00
Longeveron (LGVN) United States $0.030B 0.00
Estrella Immunopharma (ESLA) United States $0.030B 0.00
AN2 Therapeutics (ANTX) United States $0.030B 0.00
SAB Biotherapeutics (SABS) United States $0.030B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Athira Pharma (ATHA) United States $0.028B 0.00
Equillium (EQ) United States $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
LakeShore Biopharma (LSB) China $0.027B 0.00
RenovoRx (RNXT) United States $0.026B 0.00
Eyenovia (EYEN) United States $0.026B 0.00
Ocean Biomedical (OCEA) United States $0.026B 0.00
GeoVax Labs (GOVX) United States $0.025B 0.00
BioXcel Therapeutics (BTAI) United States $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
Bolt Biotherapeutics (BOLT) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
Curis (CRIS) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
Beyond Air (XAIR) United States $0.023B 0.00
UNITY Biotechnology (UBX) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Cognition Therapeutics (CGTX) United States $0.022B 0.00
BRIACELL THERAP (BCTX) Canada $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
Spruce Biosciences (SPRB) United States $0.021B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
Aprea Therapeutics (APRE) United States $0.018B 0.00
Cara Therapeutics (CARA) United States $0.018B 0.00
Cadrenal Therapeutics (CVKD) United States $0.018B 0.00
BioAffinity Technologies (BIAF) United States $0.017B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Tenax Therapeutics (TENX) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Gelteq (GELS) $0.015B 0.00
IN8bio (INAB) United States $0.015B 0.00
Cingulate (CING) United States $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
Pulmatrix (PULM) United States $0.013B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Apollomics (APLM) United States $0.012B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Vincerx Pharma (VINC) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
Evaxion Biotech (EVAX) Denmark $0.010B 0.00
Syros Pharmaceuticals (SYRS) United States $0.010B 0.00
Biora Therapeutics (BIOR) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Galecto (GLTO) Denmark $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
NKGen Biotech (NKGN) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Forte Biosciences (FBRX) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
TuHURA Biosciences (HURA) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Edesa Biotech (EDSA) Canada $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Polyrizon (PLRZ) $0.004B 0.00
Dogwood Therapeutics (DWTX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Psyence Biomedical (PBM) Canada $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Onconetix (ONCO) United States $0.001B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
Elevai Labs (ELAB) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00